Treatment library
Loading treatment roster
Preparing current medications, procedures, devices, and historical context.
Treatment library
Preparing current medications, procedures, devices, and historical context.
A rare-disease obesity therapy for specific genetic obesity syndromes. It is not a mainstream consumer weight-loss medication, but it belongs in a complete treatment library because it represents a very different obesity-treatment use case.
FDA-approved for chronic weight management in certain rare genetic obesity syndromes, not for general obesity treatment.
MC4R agonist
Coverage can be available for labeled rare-genetic indications but requires highly specific diagnosis and authorization pathways.
MC4R agonist
A rare-disease obesity therapy for specific genetic obesity syndromes. It is not a mainstream consumer weight-loss medication, but it belongs in a complete treatment library because it represents a very different obesity-treatment use case.
medication
current
2020
Imcivree
setmelanotide
Rhythm Pharmaceuticals
No.
setmelanotide
Specialty medication with very high cost, typically handled through specialty access channels rather than routine retail cash pay.
Coverage can be available for labeled rare-genetic indications but requires highly specific diagnosis and authorization pathways.
Relevant only when a patient has one of the labeled rare genetic obesity conditions and specialist evaluation confirms fit.
Imcivree matters because it shows how obesity treatment can become highly targeted when the disease mechanism is genetically specific.
Mood monitoring and hyperpigmentation concerns matter, and the drug should not be generalized to routine obesity care.
skin hyperpigmentation, nausea, injection-site reactions, headache, depression or mood changes
MC4R agonist
Subcutaneous injection with individualized dosing based on age, syndrome, and response.
Daily subcutaneous injection.
These are the official or reference sources used to anchor this treatment profile.
Treatment availability, dosing, cash pricing, and insurance coverage change often. Verify current details with your clinician, pharmacist, surgeon, device program, and insurer before starting, switching, or paying for treatment.